Skip to content

Anika Therapeutics, Inc.: filings

Every Anika Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 62 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-29fiscal Q2 2026451260001171843-26-005012
10-Q2026-04-30fiscal Q1 202645920001171843-26-002852
10-K2026-03-03fiscal FY 2025491270001171843-26-001275
10-Q2025-11-05fiscal Q3 2025451310001171843-25-007032
10-Q2025-07-30fiscal Q2 2025461270001171843-25-004826
10-Q2025-05-09fiscal Q1 202546930001171843-25-003019
10-K2025-03-17fiscal FY 2024491270001171843-25-001486
10-Q2024-11-04fiscal Q3 2024431230001171843-24-005993
10-Q2024-08-08fiscal Q2 2024431190001171843-24-004615
10-Q2024-05-08fiscal Q1 202442850001171843-24-002682
10-K2024-03-15fiscal FY 2023491280001171843-24-001380
10-Q2023-11-03fiscal Q3 2023431220001171843-23-006687
10-Q2023-08-08fiscal Q2 2023431200001171843-23-005114
10-Q2023-05-09fiscal Q1 202342860001171843-23-003106
10-K2023-03-16fiscal FY 2022481240001171843-23-001729
10-Q2022-11-09fiscal Q3 2022411210001171843-22-007281
10-Q2022-08-04fiscal Q2 2022411160001171843-22-005368
10-Q2022-05-06fiscal Q1 202241840001171843-22-003350
10-K2022-03-11fiscal FY 2021491280001171843-22-001790
10-Q2021-11-05fiscal Q3 2021421220001171843-21-007580
10-Q2021-08-06fiscal Q2 2021421180001171843-21-005594
10-Q2021-05-07fiscal Q1 202142870001171843-21-003272
10-K/A2021-04-26fiscal FY 2020481730001171843-21-002766
10-K2021-03-05fiscal FY 2020481730001171843-21-001573
10-Q2020-11-05fiscal Q3 2020421210001171843-20-007600
10-Q2020-08-07fiscal Q2 2020421170001171843-20-005715
10-Q2020-05-22fiscal Q1 202041880001171843-20-003962
10-K2020-03-06fiscal FY 2019481690001171843-20-001536
10-Q2019-10-28fiscal Q3 2019431220001171843-19-006886
10-Q2019-07-26fiscal Q2 2019431180001171843-19-004913
10-Q2019-05-06fiscal Q1 201942840001171843-19-002946
10-K2019-02-27fiscal FY 2018461660001171843-19-001243
10-Q2018-10-26fiscal Q3 2018401040001171843-18-007266
10-Q2018-07-31fiscal Q2 2018401040001171843-18-005577
10-Q2018-05-10fiscal Q1 201839800001171843-18-003806
10-K2018-02-27fiscal FY 2017461570001171843-18-001450
10-Q2017-10-27fiscal Q3 2017401070001171843-17-006367
10-Q2017-07-28fiscal Q2 201736990001171843-17-004447
10-Q2017-05-04fiscal Q1 201739800001171843-17-002682
10-K2017-02-24fiscal FY 2016451550001171843-17-001121
10-Q2016-11-01fiscal Q3 2016391040001171843-16-012756
10-Q2016-08-01fiscal Q2 2016391040001171843-16-011397
10-Q2016-05-03fiscal Q1 201639800001171843-16-009632
10-K2016-03-10fiscal FY 2015441540001171843-16-008487
10-Q2015-11-03fiscal Q3 2015391040001171843-15-005922
10-Q2015-08-04fiscal Q2 2015391050001171843-15-004303
10-Q2015-05-04fiscal Q1 201539810001171843-15-002462
10-K2015-03-13fiscal FY 2014391410001171843-15-001395
10-Q2014-11-06fiscal Q3 2014381030001171843-14-005281
10-Q2014-08-04fiscal Q2 2014391050001171843-14-003693
10-Q2014-05-05fiscal Q1 201439800001171843-14-002144
10-K2014-03-13fiscal FY 2013431590001171843-14-001240
10-Q2013-11-05fiscal Q3 2013401090001171843-13-004422
10-Q2013-08-06fiscal Q2 2013421110001157523-13-003914
10-Q2013-05-06fiscal Q1 201341840001157523-13-002386
10-K2013-03-14fiscal FY 2012441610001157523-13-001397
10-Q2012-11-08fiscal Q3 2012421110001157523-12-005906
10-Q2012-08-07fiscal Q2 2012421110001157523-12-004339
10-Q2012-05-07fiscal Q1 201239800001157523-12-002604
10-K2012-03-13fiscal FY 2011391020001157523-12-001365
10-Q2011-11-04fiscal Q3 2011391000001157523-11-006495
10-Q/A2011-08-10fiscal Q2 2011391000001157523-11-004919

Inspect the source

Entity
Anika Therapeutics, Inc. / CIK 0000898437
Captured
2026-09-20T05:04:56.960Z
SEC response SHA-256
f1da3290842851cfa646165073c3c5bf9c06212e35bc3d1892f2be77cae8b535

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000898437.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))